NATIONAL INSTITUTE FOR HEALTH AND WELFARE Modeling environmental burden of disease of asthma: Protective factors and control options as part of the TEKAISU.

Slides:



Advertisements
Similar presentations
Asthma & the Environment Oklahoma Asthma Initiative American Lung Association of the Central States.
Advertisements

Measuring burden of disease Introduction to DALYs FETP India.
Community Dentistry Years I - IV Dr David Locker Room 521 (ext 4490)
Aging Farmers: Findings from the UC Davis Farmer Cohort Marc Schenker, Diane Mitchell, Tracey Armitage Western Center for Agricultural Health.
Unit 14: Measures of Public Health Impact.
ISEE 2007 PREVALENCE STUDY OF ALLERGY DISEASES IN CHILDREN IN THE CZECH REPUBLIC Růžena Kubínová, Center of Environmental Health, National Institute of.
Summary Measures of Population Health: Measuring the impact of disease, injuries and risk factors.
The challenge of non-communicable disease in our near neighbours: a disease burden perspective Professor Alan Lopez School of Population Health The University.
A Profile of Chronic Disease in Nevada Tracey Green, MD Nevada State Health Officer January Shaping a Healthy Nevada: Making a Difference in.
Donald F. Behan Tobacco Control Network Presentation1 Economic Effects of Environmental Tobacco Smoke by Donald F. Behan, Michael P. Eriksen and Yijia.
TRENDS IN HOSPITALIZATION RATES FROM ASTHMA IN CHILDREN AND ADOLESCENTS IN POLAND Krystyna Szafraniec 1, Wieslaw Jedrychowski 1, Bogdan Wojtyniak 2 and.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
Session 5: Indoor Air, Work Performance and Productivity May 30, 2007 Building services for the young to serve the old in The Netherlands F. Franchimon.
Department of Engineering and Public Policy Carnegie Mellon University Integrated Assessment of Particulate Matter Exposure and Health Impacts Sonia Yeh.
Indicatoren voor gezondheidsimpact van fijn stof en ozon: DALYs en externe kosten Jurgen Buekers & Rudi Torfs 05/04/2011.
Non Communicable Disease
Dr. Ed Soltis Department of Neurosciences Spring 2005
Curtin University is a trademark of Curtin University of Technology CRICOS Provider Code 00301J Renee N Carey 1 and the AWES-Cancer team 1-4 The lifetime.
Introduction to Public Health January 29,
Risk Factors for Developing Asthma  Genetic characteristics  Occupational exposures  Environmental exposures.
Public Health and Prevention M6920 September 18, 2001.
Measuring Health Status
HEALTHY CARIBBEAN 2008 Revolutionizing the Prevention and Management of Lung Disease Dr. Timothy Roach FRCP FACP Head, Respiratory Unit Queen Elizabeth.
Summary of measures of population Health Farid Najafi MD PhD School of Population Health Kermanshah University of Medical Sciences.
Measurement Measuring disease and death frequency FETP India.
BOD working group BURDEN OF DISEASE IN THAILAND, 2009.
Changes in lifestyle risk factors: Health and economic impact as estimated by the population based RHS- model Inna Feldman, PhD Social.
Asthma Disparities – A Focused Examination of Race and Ethnicity on the Health of Massachusetts Residents Jean Zotter, JD Director, Asthma Prevention and.
Long-term exposure to air pollution and asthma hospitalisations in older adults: a cohort study Zorana Jovanovic Andersen ERS Conflict of interest.
Group 7 Burden of disease in Brazil. KEY HEALTH INDICATORS Years of life lost (YLLs): Years of life lost due to premature mortality. Years lived with.
Unintentional Injuries Overview. Injury Facts  Unintentional Injuries #1 cause of death for people 1 to 41 years old #1 cause of death for people 1 to.
April 6 -8, 2004 Asthma in California: Challenges in Assessment and Intervention Shanghai-California Environmental Health Conference Richard Kreutzer,
Reducing Exposure in the Home. Environmental Tobacco Smoke (ETS) Passive smoking Involuntary smoking.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
A short introduction to epidemiology Chapter 4: More complex study designs Neil Pearce Centre for Public Health Research Massey University Wellington,
P. Otorepec, M. Gregorič IVZ RS Use of rutinely collected air pollution and health data on local level for simple evaluation of health impact.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Measures of Disease Frequency, Effect and Impact Lecture by: Dr Amna Rehana Siddiqui Associate Professor Department of Family & Community Medicine September.
Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised.
The Heart and Stroke Foundation South Africa Presented by: Zulfa Abrahams (Dietician)
Asthma A Presentation on Asthma Management and Prevention.
Air pollution and its impact on health: Comparing findings in China with findings in Europe and the USA Kristin Aunan, CICERO CCICED, October 29, 2007,
How are priority issues for Australia's health identified? IDENTIFYING PRIORITY HEALTH ISSUES.
Very low CHD mortality among men aged in several states in the United States Akira Sekikawa, MD, PhD, PhD Lewis H Kuller, MD, DrPH Department of.
Global and Regional estimates of the Burden Due to Ambient Air Pollution: results from GBD ST AFRICA/MIDDLE-EAST EXPERT MEETING AND WORKSHOP ON THE.
Clearing the Air: Asthma and Indoor Air Exposures Institute of Medicine report on what is known about indoor air exposures and asthma Exposures and asthma.
Health Outcomes due to Alcohol 14 July 2005 Kanitta Bundhamcharoen MOPH.
Population prevalence of disease risk factors and economic consequences for the healthcare system - possible scenarios Inna Feldman Uppsala University.
HOW ARE PRIORITY ISSUES FOR AUSTRALIA’S HEALTH IDENTIFIED? HEALTH PRIORITIES IN AUSTRALIA.
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
The Health Status of Australia’s children Mortality and Morbidity.
Health issues in childhood. Asthma asthma Asthma is a chronic inflammatory disorder of the lung's air passages that makes them narrow in response to various.
Chapter 9: Global Perspectives on Selected Chronic Cardiovascular Diseases Chapter 10: Global Perspectives on Diabetes and Respiratory and Orthopedic Chronic.
Taina K. Lajunen, Jouni J. K. Jaakkola, and Maritta S. Jaakkola Am J Respir Crit Care Med Vol 188, Issue 7, Oct 1, 2013 호흡기내과 R2 김다래 / 장나은선생님.
Heart Disease Cancer Chronic lower respiratory diseases (example: COPD ) Stroke Diabetes.
Economic and Social Aspects of NCDs SDE Seminar Series/PAHO 25 April, 2012 Rachel Nugent.
Heart Disease Cancer Chronic lower respiratory diseases (example: COPD ) Stroke Diabetes.
Occupational Respiratory Disorders Zafar Fatmi Associate Professor & Head Division of Environmental Health Sciences Department of Community Health Sciences.
Secondhand smoke (SHS) is environmental tobacco smoke (ETS) that is inhaled involuntarily and passively. SHS is a combination of “sidestream” smoke, which.
Prevention Diabetes.
Health Effects of Secondhand Smoke (Environmental Tobacco Smoke)
Acute Respiratory Infections Control Manager
Chronic respiratory diseases: burden, population and interventions,
Clearing the Air: Asthma and Indoor Air Exposures
Racial Disparity in Smoking-Attributable Mortality, Years of Potential Life Lost: Case of Missouri Noaman Kayani, PhD Chronic Disease and Nutrition.
Noncommunicable diseases
Prevention Diabetes Dr Abir Youssef 29/11/2018.
George Washington University
Different measures of health status of Australians
Treated Chronic Disease Cost in MN: A Look Back & a Look Forward
Presentation transcript:

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Modeling environmental burden of disease of asthma: Protective factors and control options as part of the TEKAISU project Isabell Rumrich National Institute for Health and Welfare (THL) Kuopio, Finland Master Thesis in the ToxEn program University of Eastern Finland, Department of Environmental Science

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Outline Introduction Background data Associated Factors Control Policies Discussion 2

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Asthma Chronic inflammatory disease Prevalence as high as 9.4 % (2007) Currently only symptomatic treatment Pathology is characterized by miss-regulation of immune responses Various factors have been proposed to be associated with onset or symptoms: anthropogenic and natural environmental factors, lifestyle related stressors, pharmaceutical stressors, internal factors, genetic susceptibility and co-morbidities 3

NATIONAL INSTITUTE FOR HEALTH AND WELFARE IHME estimates of BoD (YLDs) in Asthma: 2% of total YLDs in 1990 and 2010 Maximum for 5-9y old (2010)  13% of total YLDs  biggest contribution to total YLD 4

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Genes Environmental Factors Lifestyle Co-morbidities Exposure Risk Ratio Exposure can be changed by relatively easy measures -Already existing policies -Development of hypothetical policies  Modelling of effect of exposure change Can not be changed Can be changed Other factors Reducible Fraction From the Model to Control Policies 5 Asthma BoD Attributable

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Selection of exposure factors 6 Literature Search Review Table Model PoliciesLack of evidence; Duplication of factors Lack of data; Lack of significance Impact on asthma burden 6 15 factors 6 factors 35 factors 235 articles Databases: PubMed, Scopus, Web of Science – WoS (ISI), SpringerLink and Science Direct (Elsevier). Search queries: asthma; asthma AND environment*; asthma AND risk; asthma AND environment* NOT atopy; asthma AND risk NOT atopy; asthma AND mechanism; asthma AND risk NOT occupation*; asthma AND environment* NOT occupation*

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Outline Introduction Background data Associated Factors Control Policies Discussion 7 Reducible Fraction Asthma BoD Attributable

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Life Table ( ) and Age Distribution 8

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Incidence & Prevalence Incidence: number of new cases in a specific period of time  number of new individuals entitled to reimburse expenses for asthma medication during one year Prevalence: number of all cases at a specific time point  total number of individuals entitled to reimburse expenses for asthma medication at the end of a year Data provided by KELA statistics 9

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Incidence and Prevalence – Total number of cases 10

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Background Rates at Baseline (2011) 11

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Burden of Disease - YLD 12

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Years Lived with Disability – Total number of years 13

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Duration estimation 14

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Outline Introduction Background data Associated Factors –Risk Factors –Protective Factors Control Policies Discussion 15 Reducible Fraction Asthma BoD Attributable

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Overview Risk Factors FactorExposed Population [%] RR/ORTarget Age [Years] Dampness and Mold151, NO , Underweight33,146 PM , SHS (child)41, SHS (adult)141, Cat Allergy71,677-8 Dampness and Mold151, Dog Allergy72, Formaldehyde21,

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Attributable incident cases and residual at baseline (2011) 17 Smoking; 0%

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Overview Protective Factors 18 FactorExposed Population [%] RR/ORTarget Age [Years] Cat200, Dog240, Breastfeeding350,484-6 Eurotium40, Penicillium40,576-12

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Prevented cases at baseline (2011) and background 19

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Outline Introduction Background data Associated Factors Control Policies –Tobacco Smoke –PM 2.5 –Dampness and Mould –Pets Discussion 20 Reducible Fraction Asthma BoD Attributable

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Summary Risk & Protective Factors Protective Factors 21 Residual; 7922

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Control Policies PolicyFactorReference TobaccoSHSKutvonen (2014); Savuton Suomi 2040 Smoking PM 2.5 Kutvonen (2014) Dampness and Mould HealthVent study PetsCat Dog 22

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Control Policies – Tobacco PolicyExposure in 2013 Change in Exposure Explanation Ban SHS: 4% Children 9% Adults Smoking: 15% (15-24y) 19% (25-44y) 29% (45-64y) 8% (65-84y) Total ban  100% reduction From 2015 onwards no exposure at all 50% Reduction In % reduction and then constant exposure 10% Reduction From Exposure 2014 annually 10% reduction 23

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Tobacco Exposure trends 24

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Impact of Tobacco Control Policy 25 Smoking

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Control Policies – PM2.5 PolicyExposure in 2013Change in Exposure Explanation Ban of Small Scale Wood Combustion (SSWC) in Urban Areas Total: 8mg/m 3 and 0,6 mg/m 3 due to SSWC Total ban  100% Reduction Annually fraction due to SSWC is deleted from total exposure Reduction of Small Scale Wood Combustion (SSWC) in Urban Areas Total: 8mg/m 3 and 0,6 mg/m 3 due to SSWC 50% Reduction Annually 50% of fraction due to SSWC is deleted from total exposure Speed Limit of 35km/h in Urban Areas Total: 8mg/m 3 and 0,7 mg/m 3 due to resuspension 40% Reduction Annually 40% of fraction due to resuspension is deleted 26

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Impact of PM2.5 Control Policy 27 Small Scale Wood Combustion

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Control Policies – Dampness and Mould PolicyExposure in 2013 Change of ExposureExplanation D&M15% of total population 50% ReductionIn % reduction to 7,5% and then constant exposure 28

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Impact of Dampness and Mold Control Policy 29

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Control Policies – Pets PolicyExposure in 2013Change in Exposure Explanation Cat Risk 20% of total Population 7% atopic  1,5% 50% increase Increase in 2015, after that constant at 3,5% Cat Protection 93% non-atopic  18,5% Increase in 2015, after that constant at 46,5 % Dog Risk 24% of total Population 7% atopic  1,8% Increase in 2015, after that constant at 3,5% Dog Protection 93% non-atopic  22,2% Increase in 2015, after that constant at 46,5% 30

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Impact of Pet Control Policy 31

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Reduction Potential of Control Policies 32 Tobacco Wood Combustion Dampness

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Impact of combined Control Policies 33

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Reducible Fraction of the total 25y cumulative Incidence 34 More realistic Most efficient

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Efficiency Control Scenarios - Incidence 35

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Efficiency Control Scenarios - Prevalence 36

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Efficiency Control Scenarios – combined Incidence & Prevalence 37

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Outline Introduction Background data Associated Factors Control Policies Discussion 38

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Limitations Population Life Table –Neglecting of (Im-)migration Use of YLD instead of DALY –Each year a very low number of death due to asthma  neglected Discounting –Discounting decreases estimates for future years compared to non-discounted estimates 39

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Uncertainties Trend estimations –Uncertainty about the future trends in asthma and exposures Evidence –Overall very weak (association with atopy) –PM source has impact on toxicological profile Duration –Duration has impact on incidence based YLD estimate  longer duration increases YLD estimate 40

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Conclusion Accumulation of prevalent cases in older age groups Asthma duration is increasing and age dependent About half of the total BoD can be theoretically explained BoD can be reduced (up to 20%) by reducing exposure to risk factors 41

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Thank you for your attention! 42

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Life Table (1986 – 2040) 43

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Age groups 44 Age GroupStartEndAbsolute 1986 % 1986 Absolute 2011 % 2011 Absolute 2040 % 2040 Infant , , ,3 Toddler , , ,8 Preschool Child , , ,7 Child , , ,2 Teen , , ,1 Young Adult , , ,7 Working Age , , ,6 Pensioner , , ,6 Elderly , , ,0 Total , , ,9 Absolute0>

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Disability Weights ,10,20,30,50,60,7 0,80,9 1 Asthma Meningitis Perfect Health Death Dental caries Acute mycardial infarction 1st stroke ever Liver neoplasm Leukemia Cretinism Severe Depressive Episode 0,4

NATIONAL INSTITUTE FOR HEALTH AND WELFARE 46

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Comparison YLD_I and YLD_P

NATIONAL INSTITUTE FOR HEALTH AND WELFARE

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Attributable YLD_I & attributable YLD_P – Comparison I Baseline (2011) 49

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Attributable YLD_I & attributable YLD_P – Comparison

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Comparison studies – Methods WHOIHMEEBoDESETURIHealthVentThesis Target year YLD estimateYLD_IYLD_PYLD_I YLD_P Disability Weight 0,040,009- 0,132 0,04 Duration15 years - - DiscountingYesNoYes No YesNo Source Asthma Data WHO? KELA statistics 51

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Comparison with other studies StudyYearFactorEstimate (YLD) Thesis (YLD) WHO2002Asthma WHO2004Asthma HealthVent2010Asthma a 2 023*2 037 HealthVent2010PM2.5 1,a 8 653*1 049 HealthVent2010SHS 2,a 278*591 HealthVent2010Dampness & Mould 3,a 340*397 EBoDE2010SHS EBoDE2010Formaldehyde90 52 * In DALYs a Includes only attributable to poor indoor air quality 1 includes asthma, lung cancer, CV-diseases, COPD 2 includes lung cancer, ischemic heart disease, asthma 3 includes respiratory infections, asthma

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Risk estimates for stressors Risk estimates for stressor were available for short window of time  linear regression used for extrapolation for longer period of time 53

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Tobacco Statistics Finland 54

NATIONAL INSTITUTE FOR HEALTH AND WELFARE PM Exposure trends 55

NATIONAL INSTITUTE FOR HEALTH AND WELFARE From change in Incidence to change in Prevalence 56

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Summary I How much of the burden of asthma can be explained by known environmental risk factors? Which are the ones with the most impact?  25-50% with PM 2.5 and SHS having the biggest impact Are there any protection factors capable of preventing a significant fraction of onset or symptoms of asthma?  Yes, but very weak evidence 57

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Summary II Are the two different modeling approaches comparable? Are differences in the burden of disease estimates due to changes in the incidence or prevalence rate?  Incidence based has bigger focus on younger age groups and prevalence based estimates have bigger focus on older age groups Does the reduction of environmental exposures lead theoretically to a reduction of burden of disease?  10% of total BoD and 30% of attributable BoD 58

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Summary III Which control policies approach has theoretically a bigger impact on DALYs?  Ban of Tobacco (SHS) and Increase of Pets Can any causality between onset and aggravation regarding environmental factors be identified?  No Does it make a difference to use a constant duration of disease or an age-dependent estimate?  Yes (assumed that duration is equal to Prev/Inc) 59

NATIONAL INSTITUTE FOR HEALTH AND WELFARE Conclusion ”Essentially, all models are wrong, but some are useful” (George Box) Many uncertainties, but nevertheless, the model gives an overview over the order of magnitude of impact of exposures on asthma  Results can be used as support for decision making in public health policies 60